Lab

You may have missed

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

admin May 18, 2025 0
AI in Liver Care Needs Vigilance and Tailoring to Population

AI in Liver Care Needs Vigilance and Tailoring to Population

admin May 16, 2025 0
Kidney Dialysis Equipment Market, In-Depth Analysis

Kidney Dialysis Equipment Market, In-Depth Analysis

admin May 16, 2025 0
KHSC expands liver cancer treatment with cutting-edge Y90 therapy

KHSC expands liver cancer treatment with cutting-edge Y90 therapy

admin May 16, 2025 0
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

admin May 14, 2025 0